Dow Up 0.36% Nasdaq Up 0.12%

More On ZLCS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Zalicus Inc. (ZLCS)

-NasdaqCM
1.18 Jul 15, 4:00PM EDT
Prev Close:1.18
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.20
Beta:1.93
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.86 - 8.28
Volume:0
Avg Vol (3m):871,832
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZLCS

Comparison

Symbol% ChgMkt Cap
ZLCS 0.00%N/A
ACT59.79B
NVS215.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

As of July 15, 2014, Zalicus Inc. was acquired by EPIRUS Biopharmaceuticals, Inc., in a reverse merger transaction. Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback